Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hepion Pharmaceuticals Inc
(NQ:
HEPA
)
0.7550
-0.0640 (-7.81%)
Streaming Delayed Price
Updated: 12:02 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hepion Pharmaceuticals Inc
< Previous
1
2
3
Next >
Stocks That Hit 52-Week Lows On Thursday
July 28, 2022
On Thursday, 108 companies set new 52-week lows.
Via
Benzinga
Hepion's Rencofilstat Combo Shows Anti-Tumor Activity In Nonclinical Liver Cancer Study
January 26, 2022
Hepion Pharmaceuticals Inc (NASDAQ: HEPA) has announced the results of a nonclinical research study showing rencofilstat (CRV431)
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 27, 2022
Wednesday saw 83 companies set new 52-week lows.
Via
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.
Via
Benzinga
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
June 21, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
June 21, 2022
Gainers Valneva SE (NASDAQ: VALN) shares rose 83.6% to $25.18 in pre-market trading following Pfizer agreement to acquire an 8.1% stake.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 19, 2022
Gainers Radius Health (NASDAQ:RDUS) stock moved upwards by 18.8% to $6.94 during Thursday's after-market session. The company's market cap stands at $330.1 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2022
February 28, 2022
Upgrades According to DA Davidson, the prior rating for Envestnet Inc (NYSE:ENV) was changed from Neutral to Buy. In the fourth quarter, Envestnet showed an EPS of $0.50, compared...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 26, 2022
Gainers Reneo Pharmaceuticals (NASDAQ:RPHM
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 24, 2022
Welcome back, trader! It's time to get this week going with a breakdown of the biggest pre-market stock movers for Monday!
Via
InvestorPlace
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
January 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hepion's Lead NASH Drug Candidate Gets The Non-Proprietary Name...
Via
Benzinga
Hepion's CRV431 Shows Encouraging Safety Profile In Drug-Drug Interaction Study
September 29, 2021
Hepion Pharmaceuticals Inc (NASDAQ: HEPA) has announced results from a Drug-Drug Interaction (DDI) study with its lead drug candidate, CRV431. CRV431 targets...
Via
Benzinga
Hepion Pharma Shares Encouraging Biomarker Data From NASH Trial
September 13, 2021
Hepion Pharmaceuticals Inc (NASDAQ: HEPA) has announced additional efficacy data from its Phase 2a AMBITION clinical trial. Related Content: Hepion Pharma's NASH...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 13, 2021
Gainers Itamar Medical (NASDAQ:ITMR) shares moved upwards by 44.37% to $29.8 during Monday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
21 Stocks Moving in Monday's Pre-Market Session
September 13, 2021
Gainers Itamar Medical Ltd. (NASDAQ: ITMR) rose 43% to $29.52 in pre-market trading. Zoll Medical said it has signed an agreement to acquire Itamar Medical for $31 per ADS in...
Via
Benzinga
Why Are Hepion Pharma Shares Moving Higher Premarket Monday?
September 13, 2021
Hepion Pharmaceuticals Inc (NASDAQ: HEPA) stock is moving higher during premarket ahead of additional data from its non-alcoholic steatohepatitis (NASH) trial....
Via
Benzinga
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week. Humanigen, Inc. (NASDAQ: HGEN) was among the biggest...
Via
Benzinga
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
September 10, 2021
Gainers Hepion Pharmaceuticals (NASDAQ:HEPA
Via
Benzinga
Hepion Pharma's NASH Candidate Aces Mid-Stage Study
July 13, 2021
Hepion Pharmaceuticals Inc (NASDAQ: HEPA) has announced positive topline results from its Phase 2a AMBITION NASH clinical trial evaluating CRV431, a potent...
Via
Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
64 Biggest Movers From Yesterday
July 14, 2021
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares climbed 128.8% to settle at $9.06 on Tuesday. Red Cat Holdings, Inc. (NASDAQ: RCAT) surged 60.3% to settle at $4.76...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 13, 2021
Gainers SCWorx (NASDAQ:WORX) stock increased by 38.34% to $3.68 during Tuesday's pre-market session. The company's market cap stands at $36.9 million. PLx Pharma (...
Via
Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
May 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.